KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.31 $2.47 Thursday, 25th Apr 2024 AKBA stock ended at $1.33. This is 2.92% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 3.05% from a day low at $1.31 to a day high of $1.35.
90 days $1.31 $2.47
52 weeks $0.780 $2.47

Historical Akebia Therapeutics prices

Date Open High Low Close Volume
Aug 19, 2020 $10.68 $10.82 $10.23 $10.26 653 563
Aug 18, 2020 $10.71 $10.84 $10.53 $10.64 774 812
Aug 17, 2020 $10.60 $10.77 $10.47 $10.66 1 159 361
Aug 14, 2020 $10.63 $10.81 $10.36 $10.53 568 852
Aug 13, 2020 $10.53 $10.83 $10.42 $10.63 824 335
Aug 12, 2020 $10.31 $10.54 $9.99 $10.50 1 461 510
Aug 11, 2020 $10.14 $10.95 $9.89 $10.28 1 390 905
Aug 10, 2020 $10.93 $11.40 $10.56 $10.67 891 803
Aug 07, 2020 $11.07 $11.57 $10.93 $10.98 905 490
Aug 06, 2020 $11.00 $11.22 $10.78 $11.06 726 981
Aug 05, 2020 $11.04 $11.23 $10.96 $11.15 818 029
Aug 04, 2020 $11.54 $11.64 $10.76 $10.94 1 266 729
Aug 03, 2020 $11.25 $11.75 $11.20 $11.59 1 265 183
Jul 31, 2020 $11.91 $11.92 $11.07 $11.17 1 004 202
Jul 30, 2020 $11.58 $12.17 $11.58 $11.91 711 898
Jul 29, 2020 $11.69 $11.87 $11.60 $11.76 758 800
Jul 28, 2020 $12.00 $12.48 $11.62 $11.62 972 837
Jul 27, 2020 $11.82 $12.17 $11.81 $12.13 743 593
Jul 24, 2020 $11.80 $12.05 $11.30 $11.76 756 036
Jul 23, 2020 $12.26 $12.64 $11.88 $11.98 779 364
Jul 22, 2020 $12.44 $12.60 $12.11 $12.25 475 300
Jul 21, 2020 $12.88 $13.00 $12.28 $12.44 932 500
Jul 20, 2020 $12.80 $13.14 $12.44 $12.88 1 066 800
Jul 17, 2020 $12.21 $12.74 $12.18 $12.36 786 600
Jul 16, 2020 $12.27 $12.31 $11.90 $12.28 641 800
Click to get the best stock tips daily for free!

About Akebia Therapeutics

Akebia Therapeutics Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citra... AKBA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT